268 related articles for article (PubMed ID: 18380400)
1. Characterization of solid-state forms of mebendazole.
Kumar S; Chawla G; Sobhia ME; Bansal AK
Pharmazie; 2008 Feb; 63(2):136-43. PubMed ID: 18380400
[TBL] [Abstract][Full Text] [Related]
2. Characterization of solid-state forms of celecoxib.
Chawla G; Gupta P; Thilagavathi R; Chakraborti AK; Bansal AK
Eur J Pharm Sci; 2003 Nov; 20(3):305-17. PubMed ID: 14592696
[TBL] [Abstract][Full Text] [Related]
3. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
Agatonovic-Kustrin S; Glass BD; Mangan M; Smithson J
Int J Pharm; 2008 Sep; 361(1-2):245-50. PubMed ID: 18555626
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.
Brusau EV; Camí GE; Narda GE; Cuffini S; Ayala AP; Ellena J
J Pharm Sci; 2008 Jan; 97(1):542-52. PubMed ID: 17854049
[TBL] [Abstract][Full Text] [Related]
5. Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity.
García-Rodriguez JJ; de la Torre-Iglesias PM; Vegas-Sánchez MC; Torrado-Durán S; Bolás-Fernández F; Torrado-Santiago S
Int J Pharm; 2011 Jan; 403(1-2):23-8. PubMed ID: 20934497
[TBL] [Abstract][Full Text] [Related]
6. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
7. The solid-state characterization of fusidic acid.
Gilchrist SE; Letchford K; Burt HM
Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
[TBL] [Abstract][Full Text] [Related]
8. Solid state investigation and characterization of the polymorphic and pseudopolymorphic forms of indapamide.
Ghugare P; Dongre V; Karmuse P; Rana R; Singh D; Kumar A; Filmwala Z
J Pharm Biomed Anal; 2010 Feb; 51(3):532-40. PubMed ID: 19796901
[TBL] [Abstract][Full Text] [Related]
9. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization of deflazacort: thermal analysis, crystallographic and spectroscopic study.
Cuffini SL; Ellena JF; Mascarenhas YP; Ayala AP; Sielser HW; Filho JM; Monti GA; Aiassa V; Sperandeo NR
Steroids; 2007 Mar; 72(3):261-9. PubMed ID: 17207826
[TBL] [Abstract][Full Text] [Related]
11. Solid-state characterization of tacrine hydrochloride.
Sorrenti M; Catenacci L; Bruni G; Luppi B; Bigucci F; Bettinetti G
J Pharm Biomed Anal; 2012 Apr; 63():53-61. PubMed ID: 22326286
[TBL] [Abstract][Full Text] [Related]
12. Solid-state characterization of two polymorphic forms of R-albuterol sulfate.
Palacio MA; Cuffini S; Badini R; Karlsson A; Palacios SM
J Pharm Biomed Anal; 2007 Mar; 43(4):1531-4. PubMed ID: 17141446
[TBL] [Abstract][Full Text] [Related]
13. Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
Llinàs A; Burley JC; Box KJ; Glen RC; Goodman JM
J Med Chem; 2007 Mar; 50(5):979-83. PubMed ID: 17298048
[TBL] [Abstract][Full Text] [Related]
14. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
[TBL] [Abstract][Full Text] [Related]
15. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
Sher P; Ingavle G; Ponrathnam S; Pawar AP
Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
[TBL] [Abstract][Full Text] [Related]
16. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
17. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C.
Martins FT; Neves PP; Ellena J; Camí GE; Brusau EV; Narda GE
J Pharm Sci; 2009 Jul; 98(7):2336-44. PubMed ID: 18855910
[TBL] [Abstract][Full Text] [Related]
18. Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques.
Chadha R; Arora P; Kaur R; Saini A; Singla ML; Jain DS
Acta Pharm; 2009 Sep; 59(3):245-57. PubMed ID: 19819822
[TBL] [Abstract][Full Text] [Related]
19. Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization.
Tong HH; Wu HB; Zheng Y; Xi J; Chow AH; Chan CK
Int J Pharm; 2008 May; 355(1-2):195-202. PubMed ID: 18207676
[TBL] [Abstract][Full Text] [Related]
20. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
